After making your discovery in the research lab, you have crucial decisions to make before transferring your intellectual property to a company or licensing firm to commercialize it. Is there new technology that should be patented, especially before you publicly disclose your invention? Should you continue with your university, or leave to join the startup company or firm licensing your technology?
Technology Transfer expert Marc Sedam of NYU Langone Health and New York University brings his wealth of experience working with scientists just like you who are making the jump from research scientist to scientific entrepreneur to provide guidance for addressing these challenging decisions and more.
Part 6 of our series on Starting a Company is moderated by Jim Skinner of Terregena Inc. and ACS SCHB and 2015 ACS President Diane Grob Schmidt of the University of Cincinnati. This event will have special introductions from 2021 ACS President H.N. Cheng of the U.S. Department of Agriculture’s Agricultural Research Service and 2022 ACS President Angela Wilson of Michigan State University, and is co-produced with the ACS Division of Small Chemical Businesses and the ACS Division of Business Development & Management.
What You Will Learn
- Can your invention be licensed or could your invention be the basis of forming a new company
- What agreements, contracts, licenses and/or other commitments would be involved with any, or all, of these decisions
- Technology transfer answers to challenging decisions and unforeseen opportunities for entrepreneurial-minded scientists
Co-Producer
The Fine Print
ACS Webinars® does not endorse any products or services. The views expressed in this presentation are those of the presenters and do not necessarily reflect the views or policies of the American Chemical Society.
;void(0);){kind=link}